Grace Therapeutics, INC. (GRCE) SEC Filings — 2024

Filings

• Grace Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Grace Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Grace Therapeutics Files 10-Q for Q2 2024 — 10-Q · Nov 13, 2024
• Grace Therapeutics Changes Fiscal Year End — 8-K · Oct 28, 2024
• Acasti Pharma Files 8-K — 8-K · Oct 25, 2024
• Acasti Pharma Enters Material Agreement, Modifies Security Holder Rights — 8-K · Oct 7, 2024
• Acasti Pharma Files 8-K: Director Changes & Shareholder Votes — 8-K · Sep 30, 2024
• Acasti Pharma Files 8-K — 8-K · Sep 25, 2024
• Acasti Pharma Inc. Proxy Statement: Your Vote Matters! — DEFA14A · Sep 6, 2024
• Acasti Pharma Relocates Principal Offices — 8-K · Aug 16, 2024
• Acasti Pharma 10-Q: Financials & Warrant Adjustments — 10-Q · Aug 9, 2024
• Acasti Pharma Files Proxy Materials — DEFA14A · Aug 7, 2024
• Acasti Pharma INC. SC 13G Filing — SC 13G · Jul 10, 2024
• Acasti Pharma Files 8-K with Office and Contact Info — 8-K · Jun 27, 2024
• Acasti Pharma Files 2024 10-K — 10-K · Jun 21, 2024
• Acasti Pharma INC. SC 13G Filing — SC 13G · Apr 9, 2024
• Acasti Pharma Files 8-K for Regulatory Disclosure — 8-K · Apr 1, 2024
• Acasti Pharma INC. SC 13G Filing — SC 13G · Feb 13, 2024
• Acasti Pharma Inc. Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 12, 2024
• Acasti Pharma 8-K: Executive Comp & Leadership Changes — 8-K · Jan 8, 2024